{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:04:53Z","timestamp":1793228693956,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","cghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.cgh.2024.01.037","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T05:19:09Z","timestamp":1707801549000},"page":"1217-1225.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Association Between Vonoprazan and the Risk of Gastric Cancer After Helicobacter pylori Eradication"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4905-7046","authenticated-orcid":false,"given":"Junya","family":"Arai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Niikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3988-2499","authenticated-orcid":false,"given":"Yoku","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sozaburo","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Fujishiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Kasuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2024.01.037_bib1","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study","volume":"5","author":"Fitzmaurice","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cgh.2024.01.037_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10120-003-0265-0","article-title":"The future of gastric cancer prevention","volume":"7","author":"Correa","year":"2004","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.cgh.2024.01.037_bib3","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1136\/gutjnl-2020-320839","article-title":"Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis","volume":"69","author":"Ford","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.01.037_bib4","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.01.028","article-title":"Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis","volume":"150","author":"Lee","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.01.037_bib5","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMoa1708423","article-title":"Helicobacter pylori therapy for the prevention of metachronous gastric cancer","volume":"378","author":"Choi","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2024.01.037_bib6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(08)61159-9","article-title":"Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial","volume":"372","author":"Fukase","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2024.01.037_bib7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.gastro.2022.03.039","article-title":"Effect of Helicobacter pylori eradication on gastric cancer prevention: updated report from a randomized controlled trial with 26.5 years of follow-up","volume":"163","author":"Yan","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.01.037_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.gie.2019.05.034","article-title":"Gastric cancer risk stratification and surveillance after Helicobacter pylori eradication: 2020","volume":"90","author":"Tan","year":"2019","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2024.01.037_bib9","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMoa2211807","article-title":"Helicobacter pylori, homologous-recombination genes, and gastric cancer","volume":"388","author":"Usui","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2024.01.037_bib10","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.gie.2021.12.033","article-title":"Machine learning-based personalized prediction of gastric cancer incidence using the endoscopic and histologic findings at the initial endoscopy","volume":"95","author":"Arai","year":"2022","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2024.01.037_bib11","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ajg.2012.179","article-title":"Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis","volume":"107","author":"Janarthanan","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.01.037_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00198-015-3365-x","article-title":"Proton-pump inhibitors and risk of fractures: an update meta-analysis","volume":"27","author":"Zhou","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.cgh.2024.01.037_bib13","doi-asserted-by":"crossref","first-page":"l1580","DOI":"10.1136\/bmj.l1580","article-title":"Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study","volume":"29","author":"Xie","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2024.01.037_bib14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","article-title":"Association of proton pump inhibitors with risk of dementia","volume":"73","author":"Gomm","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.cgh.2024.01.037_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/gutjnl-2017-314605","article-title":"Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study","volume":"67","author":"Cheung","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.01.037_bib16","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1136\/gutjnl-2017-315710","article-title":"Long-term proton pump inhibitor use is a risk factor for gastric cancer after treatment for Helicobacter pylori: a retrospective cohort analysis","volume":"67","author":"Niikura","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.01.037_bib17","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1136\/gutjnl-2020-323845","article-title":"Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea","volume":"70","author":"Seo","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.01.037_bib18","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/gutjnl-2021-325551","article-title":"OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer","volume":"71","author":"Arai","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.01.037_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/gutjnl-2021-325097","article-title":"Proton pump inhibitors and risk of gastric cancer: population-based cohort study","volume":"71","author":"Abrahami","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.01.037_bib20","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/jgh3.12583","article-title":"Nonsteroidal anti-inflammatory drugs prevent gastric cancer associated with the use of proton pump inhibitors after Helicobacter pylori eradication","volume":"5","author":"Arai","year":"2021","journal-title":"JGH Open"},{"key":"10.1016\/j.cgh.2024.01.037_bib21","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/apt.17676","article-title":"Proton pump inhibitor use and the risk of metachronous gastric cancer after H. pylori eradication in patients who underwent endoscopic resection for gastric neoplasms: a population-based cohort study","volume":"58","author":"Gong","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.01.037_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819834511","article-title":"Long-term use of proton-pump inhibitors and risk of gastric cancer: a review of the current evidence","volume":"12","author":"Cheung","year":"2019","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.cgh.2024.01.037_bib23","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.3390\/ijms20081913","article-title":"The reduction in gastric atrophy after Helicobacter pylori eradication is reduced by treatment with inhibitors of gastric acid secretion","volume":"20","author":"Niikura","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cgh.2024.01.037_bib24","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1080\/00365521.2019.1663446","article-title":"Gastric cancer and gastrin: on the interaction of Helicobacter pylori gastritis and acid inhibitory induced hypergastrinemia","volume":"54","author":"Waldum","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.01.037_bib25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/gutjnl-2017-314205","article-title":"Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota","volume":"67","author":"Ferreira","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.01.037_bib26","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gutjnl-2015-310861","article-title":"Proton pump inhibitors alter the composition of the gut microbiota","volume":"65","author":"Jackson","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.01.037_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2830227","article-title":"Serum gastrin and pepsinogen levels after administration of acid secretion inhibitors for ulcers due to endoscopic submucosal dissection in patients with early gastric cancer","volume":"2022","author":"Abuduwaili","year":"2022","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.cgh.2024.01.037_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coph.2016.08.013","article-title":"Gastrin and upper GI cancers","volume":"31","author":"Hayakawa","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.cgh.2024.01.037_bib29","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.gastha.2023.03.010","article-title":"Non-Helicobacter pylori gastric microbiome modulates prooncogenic responses and is associated with gastric cancer risk","volume":"2","author":"Niikura","year":"2023","journal-title":"Gastro Hep Advances"},{"key":"10.1016\/j.cgh.2024.01.037_bib30","first-page":"670","article-title":"Vonoprazan versus conventional proton pump inhibitor-based triple therapy as first-line treatment against Helicobacter pylori: a multicenter retrospective study in clinical practice","volume":"17","author":"Shichijo","year":"2016","journal-title":"J\u00a0Dig Dis"},{"key":"10.1016\/j.cgh.2024.01.037_bib31","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.2169\/internalmedicine.0492-17","article-title":"Efficacy of vonoprazan for gastroesophageal reflux symptoms in patients with proton pump inhibitor-resistant nonerosive reflux disease","volume":"57","author":"Niikura","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.cgh.2024.01.037_bib32","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.schres.2023.01.019","article-title":"Comparative effectiveness of long-acting injectable antipsychotics in patients with schizophrenia in Japan","volume":"252","author":"Okada","year":"2023","journal-title":"Schizophr Res"},{"key":"10.1016\/j.cgh.2024.01.037_bib33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00134-022-06941-5","article-title":"Association between COVID-19 pandemic and mental disorders in spouses of intensive care unit patients","volume":"49","author":"Ohbe","year":"2023","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cgh.2024.01.037_bib34","doi-asserted-by":"crossref","first-page":"E52","DOI":"10.1055\/a-1981-2946","article-title":"Comparison of bleeding following gastrointestinal endoscopic biopsy in patients treated with and without direct oral anticoagulants","volume":"11","author":"Konish","year":"2023","journal-title":"Endosc Int Open"},{"key":"10.1016\/j.cgh.2024.01.037_bib35","first-page":"190","article-title":"Prevalence of noncommunicable diseases in Japan using a newly developed administrative claims database covering young, middle-aged, and elderly people","volume":"5","author":"Okada","year":"2022","journal-title":"JMA J"},{"key":"10.1016\/j.cgh.2024.01.037_bib37","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/apt.17461","article-title":"Letter: potassium-competitive acid blockers may increase the risk of gastric cancer after Helicobacter pylori eradication a retrospective multicentre-cohort analysis","volume":"57","author":"Arai","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.01.037_bib38","doi-asserted-by":"crossref","first-page":"16876","DOI":"10.1002\/cam4.6313","article-title":"Association of probiotic use with nivolumab effectiveness against various cancers: a multicenter retrospective cohort study","volume":"12","author":"Arai","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.cgh.2024.01.037_bib39","first-page":"455","article-title":"Use of antibiotics and probiotics reduces the risk of metachronous gastric cancer after endoscopic resection","volume":"10","author":"Arai","year":"2021","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.cgh.2024.01.037_bib40","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/pds.5263","article-title":"Validity of claims-based algorithms for selected cancers in Japan: results from the VALIDATE-J study","volume":"30","author":"Luise","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.cgh.2024.01.037_bib41","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/sj.bjc.6605024","article-title":"Proton pump inhibitors and risk of gastric cancer: a population-based cohort study","volume":"100","author":"Poulsen","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cgh.2024.01.037_bib42","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2024.01.037_bibe1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharmaceut Stat"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524001654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524001654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T15:57:20Z","timestamp":1716566240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356524001654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1542356524001654"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2024.01.037","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Vonoprazan and the Risk of Gastric Cancer After Helicobacter pylori Eradication","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2024.01.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the AGA Institute","name":"copyright","label":"Copyright"}]}}